RAAX Performance — VanEck Real Assets ETF
Data updated: 2026-08-26
RAAX returned +13.21% year to date and +28.64% over one year to Jun 2026. Annualised returns are +19.48% over 3 years and +12.90% over 5 years. The fund beat its Financials Equity category average: $100 invested three years ago grew to $171, against $158 for the category, and to $129 over one year, against $112. Volatility over the past three years was 11.40% a year. In the 12 months to Jun 2026 the fund took in a net $888.3M, and assets reached $1.05B.
RAAX Growth of $100
What $100 invested in VanEck Real Assets ETF grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Financials Equity category average over the same months.
| Period | RAAX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $129 | $112 |
| 3 years (Jul 2023 – Jun 2026) | $171 | $158 |
| 5 years (Jul 2021 – Jun 2026) | $183 | $144 |
| Since data start (Jul 2019 – Jun 2026) | $201 | $188 |
RAAX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +13.21% |
| 1 year | +28.64% |
| 3 years (annualised) | +19.48% |
| 5 years (annualised) | +12.90% |
RAAX Annual Returns
Calendar-year total returns of VanEck Real Assets ETF, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +13.21% |
| 2025 | +27.20% |
| 2024 | +12.41% |
| 2023 | +6.15% |
| 2022 | +1.82% |
| 2021 | +28.83% |
| 2020 | −13.72% |
| 2019 (Jul–Dec) | +3.20% |
RAAX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +9.9% | +7.8% | −1.7% | +4.1% | −2.9% | −3.9% | — | — | — | — | — | — |
| 2025 | +4.5% | +0.7% | +3.1% | −2.4% | +2.4% | +3.2% | +0.9% | +3.6% | +4.7% | +0.3% | +3.1% | +0.4% |
| 2024 | −1.7% | +1.2% | +6.8% | −0.9% | +1.9% | −0.2% | +3.0% | +0.9% | +2.2% | +1.6% | +2.7% | −5.3% |
| 2023 | +5.8% | −5.6% | +1.8% | +0.7% | −5.4% | +4.0% | +5.7% | −1.8% | −2.5% | −0.9% | +3.3% | +1.6% |
| 2022 | 0.0% | +5.0% | +7.5% | −3.2% | +1.6% | −10.5% | +2.9% | −2.0% | −8.2% | +7.1% | +6.4% | −2.8% |
| 2021 | +7.2% | +4.6% | +2.3% | +4.0% | +2.9% | +0.1% | +0.5% | −0.4% | −1.1% | +7.4% | −5.1% | +3.8% |
| 2020 | −2.3% | −7.5% | −17.8% | +0.7% | +0.6% | +0.7% | +6.6% | +2.3% | −5.1% | −1.5% | +11.3% | +0.4% |
| 2019 | — | — | — | — | — | — | +0.1% | −1.2% | 0.0% | +0.5% | −1.4% | +5.3% |
RAAX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 11.40%
- 3-year Sharpe ratio: 1.31 (vs 4.5% risk-free rate)
- Best month: +9.90% (Jan 2026)
- Worst month: −5.27% (Dec 2024)
RAAX Fund Flows
Monthly money in and out of VanEck Real Assets ETF, from SEC Form N-PORT.
- 12-month net flow: $888.3M
- 12-month gross sales (incl. reinvestments): $1.3B
- Sales ÷ redemptions: 2.95×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $568.1M | $441.4M | $126.6M |
| May 2026 | $95.3M | $2.1M | $93.3M |
| Apr 2026 | $153.2M | $2.0M | $151.2M |
| Mar 2026 | $146.2M | $0 | $146.2M |
| Feb 2026 | $177.1M | $3.0M | $174.2M |
| Jan 2026 | $85.8M | $0 | $85.8M |
| Dec 2025 | $24.9M | $6.2M | $18.7M |
| Nov 2025 | $32.7M | $0 | $32.7M |
| Oct 2025 | $32.2M | $0 | $32.2M |
| Sep 2025 | $18.5M | $0 | $18.5M |
| Aug 2025 | $10.5M | $0 | $10.5M |
| Jul 2025 | $0 | $1.6M | −$1.6M |
RAAX Assets Under Management
Net assets of VanEck Real Assets ETF by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $1.05B |
| 2026-03-31 | $719.45M |
| 2025-12-31 | $259.02M |
| 2025-09-30 | $172.87M |
| 2025-06-30 | $131.98M |
| 2025-03-31 | $105.04M |
| 2024-12-31 | $91.92M |
| 2024-09-30 | $77.43M |
| 2024-06-30 | $79.03M |
| 2024-03-31 | $81.79M |
| 2023-12-31 | $108.80M |
| 2023-09-30 | $90.65M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.